Study wrapper · #880
Semaglutide alters behaviour and nucleus accumbens oscillatory activity in healthy mice.
Mosqueira A, Ansarifar S, Nabavi S, et al. Molecular brain. 2026.
DOI: 10.1186/s13041-026-01329-8PubMed: 42436546
Editor's note
A mechanistic mouse study showing semaglutide shifts behavior and nucleus accumbens oscillations even in healthy, non-diseased animals. As a single small animal study it is early-stage and does not translate directly to humans, but it is genuinely about semaglutide and adds to the growing interest in its central-nervous-system effects. Frame it as preclinical signal, not clinical evidence.
Plain-language abstract
In healthy mice, daily semaglutide altered stress- and reward-related behaviors and changed electrical activity in a brain reward region. The authors present this as a baseline for understanding the drug's broader brain effects.
Related coverage
Mixed
Hunger pain and its reduction; qualitative insight from people with schizophrenia on semaglutide.
International journal of qualitative studies on health and well-beingn=——2026
Weak / none
Design, synthesis, and stability evaluation of semaglutide-derived lactam-stapled peptide scaffolds for GLP-1R targeting.
Journal of enzyme inhibition and medicinal chemistryn=——2026
Mixed
Comparison of lifestyle, surgery, and semaglutide for weight management in endometrial cancer: a prospective observational study.
Journal of obstetrics and gynaecologyn=——2026